Patents Assigned to JC Pharma, Inc.
  • Method and composition for acute treatment of seizures
    Patent number: 10206901
    Abstract: A nasal spray composition and method for treating convulsive seizures, including epileptic seizures, and also autism behavioral events. In embodiments, the nasal spray composition contains delta-9-tetrahydrocannabinol and, optionally, terpenes such as linalool.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: February 19, 2019
    Assignee: JC Pharma, Inc.
    Inventors: Jason Allen Cranford, Donald Channing Cooper
  • METHOD AND COMPOSITION FOR ACUTE TREATMENT OF SEIZURES
    Publication number: 20180078524
    Abstract: A nasal spray composition and method for treating convulsive seizures, including epileptic seizures, and also autism behavioral events. In embodiments, the nasal spray composition contains delta-9-tetrahydrocannabinol and, optionally, terpenes such as linalool.
    Type: Application
    Filed: September 20, 2017
    Publication date: March 22, 2018
    Applicant: JC Pharma, Inc.
    Inventors: Jason Allen Cranford, Donald Channing Cooper